Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
About Us
My HPRA:
Login
Register
About Us
Our Mission, Vision and Values
What We Regulate and How We Regulate
Our Strategic Plan 2021 – 2025
Contact Us
Our Structure
Patient Forum
Publications & Forms
Standards of Service
Privacy and Data Protection
Information and transparency
Consultations
Quality Management
Recruitment
Report an Issue
Legislation
Extranets
News and Events
Information Campaigns
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Latest Updates
Safety Notices
Medicines
Safety Notices
3rd Party Publications
17.11.2022
Product Information Update – Levonorgestrel
Safety Notices
Medicines
Safety Notices
3rd Party Publications
17.11.2022
Product Information Update — Phenylephrine Hydrochloride 10 mg/ml Solution for Injection or Infusion
Publications & Forms
About Us
Publications & Forms
Guidance Documents
16.11.2022
Guide to Performance Studies Conducted in Ireland
Safety Notices
Medicines
Safety Notices
Advisory
16.11.2022
Medicinal Product Shortages - update - 16 November 2022
Publications & Forms
About Us
Publications & Forms
Guidance Documents
14.11.2022
Guide to Product Literature Standard (PLS) for Veterinary Medicinal Products
Publications & Forms
About Us
Publications & Forms
Guidance Documents
14.11.2022
FAQs on Processing the Labelling and Package Leaflet for Veterinary Medicinal Products
Safety Notices
Medicines
Safety Notices
3rd Party Publications
14.11.2022
Chlormadinone acetate and nomegestrol acetate: Important Safety Information from Theramex Ireland Ltd as approved by the HPRA (11.11.22)
Publications & Forms
About Us
Publications & Forms
Newsletters & Reports
10.11.2022
HPRA Drug Safety Newsletter Edition 109
Safety Notices
Medicines
Safety Notices
Advisory
09.11.2022
Medicinal Product Shortages - update - 9 November 2022
Safety Notices
Medicines
Safety Notices
3rd Party Publications
09.11.2022
Xalkori (crizotinib) - Important Safety Information from Pfizer Healthcare Ireland as approved by the HPRA (03.11.22)
« First
« Previous
3
4
5
6
7
8
9
10
11
Next »
Last »
Date Printed: 04/02/2023